Tag: Residual paralysis

While atracurium is an intermediate-acting neuromuscular blocker, its prolonged use, especially in the ICU, can lead to significant complications [1.2.6]. Understanding what are the prolonged effects of atracurium is critical for patient safety and optimizing recovery.

Studies show that sugammadex provides a significantly faster and more reliable reversal of neuromuscular blockade than traditional agents, presenting distinct **advantages of using sugammadex** in the operating room for improved patient outcomes. Its unique mechanism of action has transformed anesthesia practice by offering a predictable and safe recovery profile for patients following surgery.